Sirius Genomics Teams with UK Genomics Group | GenomeWeb
NEW YORK (GenomeWeb News) — Sirius Genomics will collaborate with a UK research group focused on human disease gene studies to develop the company’s pharmacogenomic test for patient response to a drug treatment for infection and sepsis.
 
Sirius said today that the United Kingdom Critical Care Genomics Group will help develop its test for responsiveness to recombinant actived Protein C, which is marketed by Eli Lilly under the name Xigris.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.